Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,552 | $296.00 | $755,392.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · nonDerivative · entry 6 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,005 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
Tax withholdingCommon Stock | 5,609 | $296.00 | $1,660,264.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · nonDerivative · entry 5 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,557 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
Exercise / conversionCommon Stock | 3,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · nonDerivative · entry 4 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on May 22, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
GrantCommon Stock | 1,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · nonDerivative · entry 3 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,735 F3 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on May 22, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
Exercise / conversionCommon Stock | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · nonDerivative · entry 2 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
GrantCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · nonDerivative · entry 1 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,809 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:10 UTC |
TOUSI SUSAN HSVP Product Development
|
Exercise / conversionPerformance Shares · Derivative | 9,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005392 · form4.xml · derivative · entry 4 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,969 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:10 UTC |
TOUSI SUSAN HSVP Product Development
|
Tax withholdingCommon Stock | 6,920 | $296.00 | $2,048,320.00 |
DisclosureSEC source: 0001127602-20-005392 · form4.xml · nonDerivative · entry 3 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,654 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:10 UTC |
TOUSI SUSAN HSVP Product Development
|
Exercise / conversionCommon Stock | 9,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005392 · form4.xml · nonDerivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:10 UTC |
TOUSI SUSAN HSVP Product Development
|
GrantCommon Stock | 4,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005392 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,605 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
SAMAD SAMSVP and CFO
|
Exercise / conversionPerformance Shares · Derivative | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005390 · form4.xml · derivative · entry 4 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,626 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on January 6, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on January 6, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on January 6, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
SAMAD SAMSVP and CFO
|
Tax withholdingCommon Stock | 4,513 | $296.00 | $1,335,848.00 |
DisclosureSEC source: 0001127602-20-005390 · form4.xml · nonDerivative · entry 3 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,894 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
SAMAD SAMSVP and CFO
|
Exercise / conversionCommon Stock | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005390 · form4.xml · nonDerivative · entry 2 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on January 6, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
SAMAD SAMSVP and CFO
|
GrantCommon Stock | 3,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005390 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,781 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on January 6, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC |
Ronaghi MostafaSVP & CTO
|
Exercise / conversionPerformance Shares · Derivative | 11,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · derivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,728 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC |
Ronaghi MostafaSVP & CTO
|
Tax withholdingCommon Stock | 8,226 | $296.00 | $2,434,896.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,506 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC |
Ronaghi MostafaSVP & CTO
|
Exercise / conversionCommon Stock | 11,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC |
Ronaghi MostafaSVP & CTO
|
GrantCommon Stock | 5,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,004 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:05 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
Exercise / conversionPerformance Shares · Derivative | 13,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005385 · form4.xml · derivative · entry 4 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,488 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:05 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
Tax withholdingCommon Stock | 9,531 | $296.00 | $2,821,176.00 |
DisclosureSEC source: 0001127602-20-005385 · form4.xml · nonDerivative · entry 3 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,112 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:05 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
Exercise / conversionCommon Stock | 13,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005385 · form4.xml · nonDerivative · entry 2 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:05 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
GrantCommon Stock | 6,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005385 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,155 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:39 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionPerformance Shares · Derivative | 35,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005375 · form4.xml · derivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,184 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:39 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 25,659 | $296.00 | $7,595,064.00 |
DisclosureSEC source: 0001127602-20-005375 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,158 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:39 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionCommon Stock | 35,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005375 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:39 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 17,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005375 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,633 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:36 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionPerformance Shares · Derivative | 7,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005374 · form4.xml · derivative · entry 4 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,624 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:36 UTC |
Dadswell CharlesSVP & General Counsel
|
Tax withholdingCommon Stock | 5,174 | $296.00 | $1,531,504.00 |
DisclosureSEC source: 0001127602-20-005374 · form4.xml · nonDerivative · entry 3 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,769 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:36 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionCommon Stock | 7,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005374 · form4.xml · nonDerivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:36 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantCommon Stock | 3,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005374 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,319 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:23 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
SaleCommon Stock | 625 | $300.24 | $187,650.00 |
DisclosureSEC source: 0001127602-20-003993 · form4.xml · nonDerivative · entry 1 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,623 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 625 shares sold ranging from $300.00 to $300.51 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. F3 · balance_after: Balance includes 70 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:51 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
GrantPerformance Shares · Derivative | 4,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004398 · form4.xml · derivative · entry 2 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Underlying: Common Stock · 4,995 shares Expires 2023-01-01 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:51 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004398 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,992 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
GrantPerformance Shares · Derivative | 6,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004419 · form4.xml · derivative · entry 2 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,243 Underlying: Common Stock · 6,243 shares Expires 2023-01-01 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
GrantCommon Stock | 2,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004419 · form4.xml · nonDerivative · entry 1 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,704 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:10 UTC |
TOUSI SUSAN HSVP Product Development
|
GrantPerformance Shares · Derivative | 6,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004416 · form4.xml · derivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,243 Underlying: Common Stock · 6,243 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:10 UTC |
TOUSI SUSAN HSVP Product Development
|
GrantCommon Stock | 2,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004416 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,620 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 74 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:08 UTC |
SAMAD SAMSVP and CFO
|
GrantPerformance Shares · Derivative | 4,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004413 · form4.xml · derivative · entry 2 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 4,370 shares Expires 2023-01-01 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:08 UTC |
SAMAD SAMSVP and CFO
|
GrantCommon Stock | 1,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004413 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,468 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:03 UTC |
Ronaghi MostafaSVP & CTO
|
GrantPerformance Shares · Derivative | 4,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004411 · form4.xml · derivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Underlying: Common Stock · 4,995 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:03 UTC |
Ronaghi MostafaSVP & CTO
|
GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004411 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,140 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 68 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:00 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
GrantPerformance Shares · Derivative | 6,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004410 · form4.xml · derivative · entry 2 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,243 Underlying: Common Stock · 6,243 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:00 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
GrantCommon Stock | 2,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004410 · form4.xml · nonDerivative · entry 1 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,022 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 53 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:58 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
GrantPerformance Shares · Derivative | 7,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004406 · form4.xml · derivative · entry 2 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,492 Underlying: Common Stock · 7,492 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:58 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
GrantCommon Stock | 2,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004406 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,411 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 69 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:54 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 5,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004400 · form4.xml · derivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,619 Underlying: Common Stock · 5,619 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:54 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantCommon Stock | 1,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004400 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,106 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 63 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:56 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
GrantPerformance Shares · Derivative | 999 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004403 · form4.xml · derivative · entry 2 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999 Underlying: Common Stock · 999 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:56 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
GrantCommon Stock | 999 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004403 · form4.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,240 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 88 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:49 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantPerformance Shares · Derivative | 3,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004396 · form4.xml · derivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,746 Underlying: Common Stock · 3,746 shares Expires 2023-01-01 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.